Article 2 Matters shall be referred to the Committee by the chairman pursuant to the relevant provisions of Regulation (EEC) No 2309/93, Directive 75/319/EEC or Directive 81/851/EEC.
Article 3 Where the opinion of the Committee is obtained by written procedure the following provisions shall apply: The chairman shall send to the members of the Committee the draft decision on which its opinion is requested in the manner set out in Article 7.
Article 4 Where, in the opinion of the Commission, written comments put forward by a Member State under the procedure laid down in Article 3 raise important new questions of a scientific or technical nature which have not been dealt with in the opinion delivered by the European Agency for the Evaluation of Medicinal Products, the chairman shall suspend the procedure and the Commission shall refer the matter to the Agency for further examination.
Article 6 Where the draft decision needs to be examined at a meeting of the Committee, the notice convening the meeting, the agenda and, in the circumstances referred to in the second paragraph of Article 2, the draft decision on which the Committee's opinion is requested shall be sent by the chairman to the members of the Committee in the manner set out in Article 7.
Article 8 This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Communities.
Done at Brussels, 7 July 1995.
For the Commission Martin BANGEMANN Member of the Commission (1) OJ No L 214, 24. 8. 1993, p. 1. (2) OJ No L 147, 9. 6. 1975, p. 13. (3) OJ No L 317, 6. 11. 1981, p. 1.
